1 NO. NCH 024/2562 July 11, 2019 Subject : Notice of setting up a new subsidiary under joint venture agreement to cover intermediate care and wellness business Attn. : Director and Manager The Stock
ที่ NCH 23/2549 1 ท่ี NCH 024/2562 วนัที่ 11 กรกฎาคม 2562 เร่ือง แจ้งการร่วมทนุจดัตัง้บริษทัยอ่ยแหง่ใหม ่เพื่อรองรับธุรกจิ Intermediate care และ Wellness เรียน กรรมการ และผู้จดัการ ตลาดหลกัทรัพย์แหง่
the main businesses, the business restructuring of MK Group since 2016 has helped to ease the impact of the economic slowdown. In addition, the Company has planned to launch the wellness business at the
decreased in sales. MK Group was preparing to launch the new business which was Wellness business. The Company incurred pre-opening expenses. MK planned to launched the Wellness business during the fourth
his/her signature; however, if the cause of such person’s inability to affix signature is the inability to appreciate the nature of one’s act or to control oneself owing to physical or mental illness
is a result of such person being unconscious or unable to control oneself due to a physical illness or a mental disorder, the offeror is not required to have such person affix signature in the
% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60
-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 1st Quarter 2020 1st Quarter 2019 Change MB % MB % MB % 1. Wellness & Anti-Aging 47.77 49.18 31.87 37.52 15.90 49.90% 2. Aesthetic
increased in revenues from sales of medicated pet shampoo, pet foods products, livestock animal products, and revenues from sales of wellness & anti-aging products and aesthetic innovations products. 2. Cost
shares of WCI Holding PCL, held by EFORL. As coronavirus situation may impact to the business which is unable to be expected, the Board of Director meeting considers that the investment in wellness